About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries.

Nov. 13, 2024 — A new study by medicine safety experts found the use of gabapentinoids -- medicines widely used to treat neuropathic pain -- increased the risk of hip fractures, especially in ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

It wasn’t until the first time that I saw someone else with vitiligo in person that my perception changed. This stranger didn’t seem to have a care in the world about his spots. He seemed so ...

Warning over popular medication. Picture ... research is now needed to confirm our findings, given its minimal pain-relief effect, the use of paracetamol as a first-line pain killer for long ...

The Food and Drug Administration (FDA) hasn’t approved any medications containing CBD for pain relief, and additional research is necessary to determine CBD’s ability to reduce pain ...